2. Search Result
Search Result
Results for "

Delivery systems

" in MedChemExpress (MCE) Product Catalog:

63

Inhibitors & Agonists

1

Fluorescent Dye

48

Biochemical Assay Reagents

7

Peptides

4

Natural
Products

Targets Recommended:
Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-145782
    Witepsol

    		Liposome Metabolic Disease
    Witepsol is a selective lipid-based vehicle for use in drug delivery systems .
    Witepsol
  • HY-142987
    Linoleyl methane sulfonate

    		Liposome Metabolic Disease
    Linoleyl methane sulfonate is a selective lipid-based vehicle for use in drug delivery systems .
    Linoleyl methane sulfonate
  • HY-W763806
    Zein

    		Biochemical Assay Reagents Others
    Zein is a plant protein‐based polymer, can be used to prepare nanofibrous mats through electrospun. Zein has good cell compatibility and easy fabrication ability, and can be used in drug delivery systems .
    Zein
  • HY-106828
    E2-CDS

    Estradiol 17-Dihydrotrigonelline

    		 Others Metabolic Disease
    E2-CDS (Estradiol 17-Dihydrotrigonelline) is a redox-based chemical delivery system for estradiol (E2). E2-CDS is capable of sustained and brain-selective delivery of estradiol .
    E2-CDS
  • HY-149664
    3β-[N-(N′,N′-Dimethylaminoethyl)carbamoyl]cholesterol

    DC-Chol

    		 Liposome Cancer
    3β-[N-(N′,N′-Dimethylaminoethyl)carbamoyl]cholesterol, a lipid, has been investigated in cancer gene therapy and vaccine delivery system .
    3β-[N-(N′,N′-Dimethylaminoethyl)carbamoyl]cholesterol
  • HY-145396
    PLGA-PEG-NH2

    		Others Cancer
    PLGA-PEG-NH2 is a material to synthesis nanomicelles. PLGA-PEG-NH2 nanomicelle is an efficient delivery system of Irinotecan for targeted colorectal cancer and hepatocellular carcinoma .
    PLGA-PEG-NH2
  • HY-145941
    AETA

    2-Acryloxyethyltrimethylammonium chloride

    		 Biochemical Assay Reagents Inflammation/Immunology
    AETA (2-Acryloxyethyltrimethylammonium chloride) can be used for the synthesis of hydrophilic polymers and hydrogels. Hydrogels are used for membranes, catheters, contact lenses, and drug delivery systems .
    AETA
  • HY-156154
    Caspase-3 activator 1

    		Pyroptosis Cancer
    Caspase-3 activator 1 (compound 4b) is a Ru(III) metal complex that inhibits gastric tumor growth and metastasis. Caspase-3 activator 1 mediates caspase-3 cleavage, which in turn causes Caspase-3 to cleave gasdermin E (GSDME) to produce the GSDME-N terminus, causing gastric tumor cell membrane perforation. Caspase-3 activator 1 is capable of inducing pyroptosis and pyroptosis-induced immune responses and can be assembled with decitabine DCT (HY-A0004) into a 4b-DCT-Lip lipid delivery system .
    Caspase-3 activator 1
  • HY-N7131
    Coumarin 6
    4 Publications Verification

    		 Fluorescent Dye Others
    Coumarin 6, a fluorescent dye, is used as a fluorescent probe in a microparticle drug delivery system to conduct in vivo tracking, cell uptake, and transport mechanism studies of drug delivery systems (λexc=450 nm, λem=505 nm) .
    Coumarin 6
  • HY-142986
    Dlin-MeOH

    		Liposome Others
    Dlin-MeOH is a lipid product for use in drug delivery systems .
    Dlin-MeOH
  • HY-144007
    Chol-PEG

    		Liposome Others
    Chol-PEG is a nonionic surfactant vesicles and can be used for a blood-persistent drug delivery system .
    Chol-PEG
  • HY-155918
    mPEG-CHO (MW 1000)

    mPEG-Aldehyde (MW 1000)

    		 Liposome Others
    mPEG-CHO (MW 1000) participates in the formation of a three-dimensional porous scaffold that carries active substances to form a delivery vehicle. The -CHO functional group interacts with the -NH2 functional group of the chitosan chain to form a glutaraldehyde-type adduct to functionalize mPEG. This functionalization and cross-linking can affect the rigidity of the delivery system, allowing slow release of the cross-linked conjugate system.
    mPEG-CHO (MW 1000)
  • HY-148363
    Heptadecan-9-yl 8-((6-(decyloxy)-6-oxohexyl)(2-hydroxyethyl)amino)octanoate

    		Liposome Inflammation/Immunology
    Heptadecan-9-yl 8-((6-(decyloxy)-6-oxohexyl)(2-hydroxyethyl)amino)octanoate can be used in lipid nanoparticles (LNP) delivery systems for mRNA vaccine delivery .
    Heptadecan-9-yl 8-((6-(decyloxy)-6-oxohexyl)(2-hydroxyethyl)amino)octanoate
  • HY-Y0873O
    PEG35000

    Polyethylene glycol 35000

    		 Biochemical Assay Reagents Others
    PEG35000 is a polyethylene glycol with a molecular weight of 35,000 that can be used as a carrier material and modifier in drug delivery systems .
    PEG35000
  • HY-155915
    mPEG-CHO (MW 350)

    mPEG-Aldehyde (MW 350)

    		 Liposome Others
    mPEG-CHO (MW 350) participates in the formation of a three-dimensional porous scaffold which carries active substances to form a delivery vehicle. The -CHO functional group interacts with the -NH2 functional group of the chitosan chain to form a glutaraldehyde-type adduct to functionalize mPEG. This functionalization and cross-linking can affect the rigidity of the delivery system, allowing slow release of the cross-linked conjugate system.
    mPEG-CHO (MW 350)
  • HY-155916
    mPEG-CHO (MW 550)

    mPEG-Aldehyde (MW 550)

    		 Liposome Others
    mPEG-CHO (MW 550) participates in the formation of a three-dimensional porous scaffold which carries active substances to form a delivery vehicle. The -CHO functional group interacts with the -NH2 functional group of the chitosan chain to form a glutaraldehyde-type adduct to functionalize mPEG. This functionalization and cross-linking can affect the rigidity of the delivery system, allowing slow release of the cross-linked conjugate system.
    mPEG-CHO (MW 550)
  • HY-155917
    mPEG-CHO (MW 750)

    mPEG-Aldehyde (MW 750)

    		 Liposome Others
    mPEG-CHO (MW 750) participates in the formation of a three-dimensional porous scaffold which carries active substances to form a delivery vehicle. The -CHO functional group interacts with the -NH2 functional group of the chitosan chain to form a glutaraldehyde-type adduct to functionalize mPEG. This functionalization and cross-linking can affect the rigidity of the delivery system, allowing slow release of the cross-linked conjugate system.
    mPEG-CHO (MW 750)
  • HY-155919
    mPEG-CHO (MW 2000)

    mPEG-Aldehyde (MW 2000)

    		 Liposome Others
    mPEG-CHO (MW 2000) participates in the formation of a three-dimensional porous scaffold which carries active substances to form a delivery vehicle. The -CHO functional group interacts with the -NH2 functional group of the chitosan chain to form a glutaraldehyde-type adduct to functionalize mPEG. This functionalization and cross-linking can affect the rigidity of the delivery system, allowing slow release of the cross-linked conjugate system.
    mPEG-CHO (MW 2000)
  • HY-155920
    mPEG-CHO (MW 3400)

    mPEG-Aldehyde (MW 3400)

    		 Liposome Others
    mPEG-CHO (MW 3400) participates in the formation of a three-dimensional porous scaffold which carries active substances to form a delivery vehicle. The -CHO functional group interacts with the -NH2 functional group of the chitosan chain to form a glutaraldehyde-type adduct to functionalize mPEG. This functionalization and cross-linking can affect the rigidity of the delivery system, allowing slow release of the cross-linked conjugate system.
    mPEG-CHO (MW 3400)
  • HY-155921
    mPEG-CHO (MW 5000)

    mPEG-Aldehyde (MW 5000)

    		 Liposome Others
    mPEG-CHO (MW 5000) participates in the formation of a three-dimensional porous scaffold which carries active substances to form a delivery vehicle. The -CHO functional group interacts with the -NH2 functional group of the chitosan chain to form a glutaraldehyde-type adduct to functionalize mPEG. This functionalization and cross-linking can affect the rigidity of the delivery system, allowing slow release of the cross-linked conjugate system.
    mPEG-CHO (MW 5000)
  • HY-155922
    mPEG-CHO (MW 10000)

    mPEG-Aldehyde (MW 10000)

    		 Liposome Others
    mPEG-CHO (MW 10000) participates in the formation of a three-dimensional porous scaffold which carries active substances to form a delivery vehicle. The -CHO functional group interacts with the -NH2 functional group of the chitosan chain to form a glutaraldehyde-type adduct to functionalize mPEG. This functionalization and cross-linking can affect the rigidity of the delivery system, allowing slow release of the cross-linked conjugate system.
    mPEG-CHO (MW 10000)
  • HY-155923
    mPEG-CHO (MW 20000)

    mPEG-Aldehyde (MW 20000)

    		 Liposome Others
    mPEG-CHO (MW 20000) participates in the formation of a three-dimensional porous scaffold which carries active substances to form a delivery vehicle. The -CHO functional group interacts with the -NH2 functional group of the chitosan chain to form a glutaraldehyde-type adduct to functionalize mPEG. This functionalization and cross-linking can affect the rigidity of the delivery system, allowing slow release of the cross-linked conjugate system.
    mPEG-CHO (MW 20000)
  • HY-N1446A
    Glycerol Monoleate

    		Endogenous Metabolite Others
    Glycerol Monoleate is a nontoxic, biodegradable and biocompatible, lipophilic glycerol fatty acid ester. Glycerol monooleate has hemolytic properties. glycerol monooleate is used as an emulsifier and an absorption enhancer in combination with bile salts. Glycerol Monoleate can be used in drug delivery systems and siRNA delivery in Vitro .
    Glycerol Monoleate
  • HY-112756
    PEG2000-DGG

    		Liposome Others
    PEG2000-DGG is a synthetic lipid. PEG2000-DGG can be used in lipid-based nanoparticle (LNP) delivery systems .
    PEG2000-DGG
  • HY-P5840
    Cyclo(RGDyC)

    		Biochemical Assay Reagents Liposome Cancer
    Cyclo(RGDyC) is a cyclic pentapeptide with anti-angiogenic abilities. Cyclo(RGDyC) can be combined with liposome delivery systems for research on ocular neovascular diseases and cancer .
    Cyclo(RGDyC)
  • HY-W441014
    DSPE-PEG-NHS, MW 2000

    		Liposome Others
    DSPE-PEG-NHS, MW 2000 is a pegylated phospholipid derivatives which can be used to prepare liposome or lipid nanoparticles for targeted drug delivery system, such as DNA or mRNA vaccine.
    DSPE-PEG-NHS, MW 2000
  • HY-W441012
    DSPE-PEG-NHS, MW 600

    		Liposome Others
    DSPE-PEG-NHS, MW 600 is a pegylated phospholipid derivatives which can be used to prepare liposome or lipid nanoparticles for targeted drug delivery system, such as DNA or mRNA vaccine.
    DSPE-PEG-NHS, MW 600
  • HY-W133967
    Calcium alginate

    		Biochemical Assay Reagents Inflammation/Immunology
    Calcium alginate is a biopolymer that can be used for developing oral agent-delivery systems . Calcium alginate is a pH sensitive hydrogel stable in acidic media and soluble in basic media .
    Calcium alginate
  • HY-Y0850
    Polyvinyl alcohol

    Polyvinyl alcohol is a biodegradable semi-crystalline synthetic polymer with a high degree of biocompatibility in vitro and in vivo. Polyvinyl alcohol can be used in the study of drug delivery system in cancer .
    Polyvinyl alcohol
  • HY-W441016
    DSPE-PEG-NHS, MW 5000

    		Biochemical Assay Reagents Others
    DSPE-PEG-NHS, MW 5000 is a pegylated phospholipid derivatives which can be used to prepare liposome or lipid nanoparticles for targeted drug delivery system, such as DNA or mRNA vaccine .
    DSPE-PEG-NHS, MW 5000
  • HY-W441015A
    DSPE-m-PEG-NHS (MW 3400)

    		Liposome Others
    DSPE-m-PEG-NHS (MW 3400) is a pegylated phospholipid derivatives which can be used to prepare liposome or lipid nanoparticles for targeted drug delivery system, such as DNA or mRNA vaccine.
    DSPE-m-PEG-NHS (MW 3400)
  • HY-132828
    Odatroltide

    DHDMIQK(KAP)

    		 P-selectin Cardiovascular Disease Metabolic Disease Inflammation/Immunology
    Odatroltide, as a nanoscale P-selectin inhibitor, is a nano-delivery system of 6,7-dihydroxyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid and KPAK to target the thrombus .
    Odatroltide
  • HY-143692
    SQDG

    		Liposome Metabolic Disease
    SQDG is a glycolipid that possesses sugar moieties in their head groups. SQDG is a membrane lipid that can be used to investigate the effects of structural lipid in LNP formulations .
    SQDG
  • HY-143210
    Transfectam

    		Liposome Metabolic Disease
    Transfectam is a cationic lipid able to interact with DNA to form complexes that mediate efficient gene transfer into various eukaryotic cells .
    Transfectam
  • HY-142985
    Oleyl Mesylate

    		Biochemical Assay Reagents Metabolic Disease
    Oleyl Mesylate is a derivative of Oleyl Alcohol. Oleyl Alcohol has been incorporated into various formulations for drug delivery .
    Oleyl Mesylate
  • HY-W440896
    DSPE-PEG-SH, MW 2000

    		Liposome
    DSPE-PEG-SH, MW 2000 is a pegylated phospholipid with thiol group which is reactive with maleimide to form a covalent thioether linkage. The amphiphatic polymer can form lipid bilayer in aqueous solution and be used to encapsulate agents for drug delivery system, such as mRNA vaccine.
    DSPE-PEG-SH, MW 2000
  • HY-125619
    1,2-Dioctanoyl-sn-glycero-3-phosphocholine

    		Liposome Others
    1,2-dioctanoyl-sn-glycero-3-phosphocholine, is a phospholipid commonly used as a component of liposome formulations and drug delivery systems. 1,2-dioctanoyl-sn-glycero-3-phosphocholine has unique chemical properties that allow it to form stable bilayers and vesicles, allowing drug encapsulation and delivery to specific targets in the body. It acts as a stabilizer and emulsifier, which can improve the solubility and bioavailability of drugs.
    1,2-Dioctanoyl-sn-glycero-3-phosphocholine
  • HY-103522
    AA29504

    		GABA Receptor Neurological Disease
    AA29504 is a ethyl carbamate with γ-aminobutyric acid (GABAA(HY-L120) receptor activity. AA29504 inhibits the delivery of the neurotransmitter gamma-aminobutyric acid in the central nervous system. AA29504 can be used to research anxiety, insomnia and other neuropsychiatric diseases .
    AA29504
  • HY-P5021
    Cyclo(Arg-Gly-Asp-(D-Phe)-Glu)

    c(RGDfE)

    		 Biochemical Assay Reagents Cancer
    Cyclo(Arg-Gly-Asp-(D-Phe)-Glu) (c(RGDfE)) is a cyclic RGD peptide that serves as a conjugated multifunctional nanodrug delivery system to target Gemcitabine to pancreatic cancer cells. Cyclo(Arg-Gly-Asp-(D-Phe)-Glu) can be used in cancer research .
    Cyclo(Arg-Gly-Asp-(D-Phe)-Glu)
  • HY-153137
    Tri-N-tridecyl 3-(ethyl(methyl)amino)propanoate

    304O13

    		 Liposome Cancer
    Tri-N-tridecyl 3-(ethyl(methyl)amino)propanoate is a biodegradable lipid prepared by the conjugate addition of alkylamines to acrylates. Tri-N-tridecyl 3-(ethyl(methyl)amino)propanoate can be used in various drug delivery systems to deliver polynucleotides, siRNA for example .
    Tri-N-tridecyl 3-(ethyl(methyl)amino)propanoate
  • HY-109506
    DPPC
    3 Publications Verification

    129Y83

    		 Liposome Endogenous Metabolite Others
    DPPC (129Y83) is a phosphoglyceride that can be used to prepare lipid monolayers, bilayers, and liposomes. DPPC is the main lipid component of pulmonary surfactant. Dppc-liposome can be effectively used as a delivery vector to induce an immune response against GSL antigen in mice .
    DPPC
  • HY-144009
    DSPE-PEG-Folate, MW 3350

    		Liposome Cancer
    DSPE-PEG-Folate, MW 3350 is a PEG derivative containing folic acid. DSPE-PEG-Folate has a targeting effect and bind to folate receptors in cancer cells. DSPE-PEG-Folate form micelles/lipid bilayer and can be used to targeted drug delivery system research .
    DSPE-PEG-Folate, MW 3350
  • HY-W440888
    DSPE-PEG-Folate, MW 2000

    		Liposome Others
    DSPE-PEG-Folate, MW 2000 is a PEG derivative containing folic acid. DSPE-PEG-Folate, MW 2000 has a targeting effect and bind to folate receptors in cancer cells. DSPE-PEG-Folate, MW 2000 form micelles/lipid bilayer and can be used to targeted drug delivery system research.
    DSPE-PEG-Folate, MW 2000
  • HY-W440890
    DSPE-PEG-Folate, MW 5000

    		Liposome Cancer
    DSPE-PEG-Folate, MW 5000 is a PEG derivative containing folic acid. DSPE-PEG-Folate, MW 5000 has a targeting effect and bind to folate receptors in cancer cells. DSPE-PEG-Folate, MW 5000 form micelles/lipid bilayer and can be used to targeted drug delivery system research .
    DSPE-PEG-Folate, MW 5000
  • HY-155902B
    Mal-PEG-OH (MW 1000)

    Maleimide-PEG-Hydroxy (MW 1000)

    		 Liposome Others
    Mal-PEG-OH (MW 1000) was used as a macroinitiator to obtain amphiphilic diblock copolymers by ring-opening polymerization of LA. Nanoparticles prepared using amphiphilic block copolymers can form active drug delivery systems. Nanoparticles encapsulate Triptolide (HY-32735), which can avoid the disadvantage of Triptolide’s poor water solubility and reduce its toxicity.
    Mal-PEG-OH (MW 1000)
  • HY-155902
    Mal-PEG-OH (MW 5000)

    Maleimide-PEG-Hydroxy (MW 5000)

    		 Liposome Others
    Mal-PEG-OH (MW 5000) can be used as a macroinitiator to obtain amphiphilic diblock copolymers by ring-opening polymerization of LA. Nanoparticles prepared using amphiphilic block copolymers can form active drug delivery systems. Nanoparticles encapsulate Triptolide (HY-32735), which can avoid the disadvantage of Triptolide’s poor water solubility and reduce its toxicity.
    Mal-PEG-OH (MW 5000)
  • HY-155902A
    Mal-PEG-OH (MW 2000)

    Maleimide-PEG-Hydroxy (MW 2000)

    		 Liposome Others
    Mal-PEG-OH (MW 2000) can be used as a macroinitiator to obtain amphiphilic diblock copolymers by ring-opening polymerization of LA. Nanoparticles prepared using amphiphilic block copolymers can form active drug delivery systems. Nanoparticles encapsulate Triptolide (HY-32735), which can avoid the disadvantage of Triptolide’s poor water solubility and reduce its toxicity.
    Mal-PEG-OH (MW 2000)
  • HY-137499
    NT1-O12B

    		Liposome Endogenous Metabolite Neurological Disease
    NT1-O12B, an endogenous chemical and a neurotransmitter-derived lipidoid (NT-lipidoid), is an effective carrier for enhanced brain delivery of several blood-brain barrier (BBB)-impermeable cargos. Doping NT1-O12B into BBB-impermeable lipid nanoparticles (LNPs) gives the LNPs the ability to cross the BBB. NT-lipidoids formulation not only facilitate cargo crossing of the BBB, but also delivery of the cargo into neuronal cells for functional gene silencing or gene recombination .
    NT1-O12B
  • HY-138170
    ALC-0315
    5+ Cited Publications

    		 Liposome SARS-CoV Infection
    ALC-0315 is an ionisable aminolipid that is responsible for mRNA compaction and aids mRNA cellular delivery and its cytoplasmic release through suspected endosomal destabilization. ALC-0315 can be used to form lipid nanoparticle (LNP) delivery vehicles. Lipid-Nanoparticles have been used in the research of mRNA COVID-19 vaccine .
    ALC-0315
  • HY-112760
    18:0 mPEG2000 PE sodium
    1 Publications Verification

    DSPE-mPEG2000 sodium; 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] sodium

    		 Liposome Cancer
    18:0 mPEG2000 PE sodium can be used for the preparation of stabilized nucleic acid-lipid particllipid particles (SNALPs). SNALPs represent some of the earliest and best functional siRNA-ABC nanoparticles described .
    18:0 mPEG2000 PE sodium

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: